“It’s not a matter of weeks, it’s a matter of days,” Albert Borla, president and CEO of Pfizer, told ABC News on Sunday.
Currently, immunizations Kovid-19 Approved only for children over 12 years of age, which raises concerns among health professionals as children begin their school years Delta variant, More transferable, spreads.
According to data recently published by the American Academy of Pediatrics, 26% of Kovid-19 cases in the US have been reported in children. On Sunday (26), an average of 266 children were hospitalized with Kovid-19 in the past week US Center for Disease Control and Prevention (CDC).
Once the Pfizer / Bioentech data is available, they will have to go through two committees, one for the FDA and one for the CDC, the medical analyst said. CNNDr. Jonathan Rainer, Domingo no.
He added that if the data is sent this week, it will be on the committee by the end of October. They have a lot of data to look at, he said.
“This is a pediatric vaccine, so dose adjustment – both in terms of efficacy and side effects – is crucial,” Rainer said.
But even if a vaccine is available, it can be difficult to vaccinate children. According to one analysis, less than half of U.S. adolescents are fully immunized against Kovid-19. CNN Of CDC data.
In response, authorities need to do a better job of educating the public about the importance of immunization for the overall health of their children and families, Rainer said.
“If you want your children to go to school, the best way to keep them there is to prevent them from taking Covid-19,” he said.
The CDC also recommends the use of masks for students, teachers and visitors in schools from kindergarten to grade 12, as well as testing on the basis of good ventilation, physical distance, and screening, until immunizations are allowed for young children.
“We know how to keep them safe,” CDC director Rochelle Valensky told CBS on Sunday. “When we don’t use the right simplification, the chances of an explosion are high.”
Normal life within a year
Bourla also echoed the recent statement of the CEO of Modern Pharmaceuticals It is likely to return to normal life in about a year.
“Within a year, I agree we can return to normal life,” Bourla said in an ABC News interview.
However, he added that this does not mean that the Kovid-19 variants will no longer exist or that a new dose of the vaccine will not be needed.
“I think the most likely scenario is an annual renovation, but we are not sure. We have to wait to see the data, ”he concluded.
(* Information from Madeline Holcomb, CNN)
Musicaholic. Twitter guru. Total bacon fanatic. Zombie ninja. Freelance student. Coffee fan. Gamer.